How To Use HCPCS Code A9600

HCPCS code A9600 describes the therapeutic use of Strontium sr-89 chloride per millicurie. This code is used to identify the specific treatment involving the administration of Strontium sr-89 chloride for therapeutic purposes. In this article, we will explore the details of HCPCS code A9600, including its official description, procedure, usage guidelines, billing requirements, historical information, and coverage by Medicare and other insurance providers.

1. What is HCPCS A9600?

HCPCS code A9600 is used to identify the therapeutic use of Strontium sr-89 chloride per millicurie. This code specifically refers to the administration of Strontium sr-89 chloride for therapeutic purposes. It is important to note that this code is not applicable for maintenance purposes and is subject to carrier judgment for coverage.

2. Official Description

The official description of HCPCS code A9600 is “Strontium sr-89 chloride, therapeutic, per millicurie.” The short description for this code is “Sr89 strontium.”

3. Procedure

1. The procedure for HCPCS code A9600 involves the administration of Strontium sr-89 chloride to the patient.
2. The healthcare provider calculates the appropriate dosage of Strontium sr-89 chloride based on the patient’s condition and treatment plan.
3. The provider prepares the Strontium sr-89 chloride solution according to the manufacturer’s instructions.
4. The solution is then administered to the patient via the appropriate route, such as intravenous injection.
5. The provider closely monitors the patient during and after the administration of Strontium sr-89 chloride to ensure safety and efficacy.

4. When to use HCPCS code A9600

HCPCS code A9600 should be used when the healthcare provider administers Strontium sr-89 chloride for therapeutic purposes. This treatment is typically used for patients with certain types of cancer, such as bone metastases, to help alleviate pain and improve quality of life. It is important to follow the specific guidelines and eligibility criteria set by the carrier to determine the appropriate use of this code.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code A9600, healthcare providers need to ensure proper documentation of the administration of Strontium sr-89 chloride. This includes documenting the dosage administered, the route of administration, and any relevant patient information. It is also important to follow the specific billing guidelines and requirements set by the insurance carrier to ensure accurate and timely reimbursement.

6. Historical Information and Code Maintenance

HCPCS code A9600 was added to the Healthcare Common Procedure Coding System on January 01, 1998. Since its addition, there have been no maintenance actions taken for this code, as indicated by the action code N, which means no maintenance for this code. This code has been in use since its addition and continues to be an important code for the therapeutic use of Strontium sr-89 chloride.

7. Medicare and Insurance Coverage

Medicare and other insurance providers may cover the therapeutic use of Strontium sr-89 chloride under HCPCS code A9600. The pricing indicator code 57 indicates that the pricing for this code is determined by other carriers. The multiple pricing indicator code A signifies that this code is not applicable as HCPCS priced under one methodology. It is important to verify coverage and reimbursement policies with the specific insurance provider to ensure proper billing and reimbursement.

8. Examples

Here are five examples of scenarios where HCPCS code A9600 may be billed:

1. A patient with advanced prostate cancer receives Strontium sr-89 chloride therapy to manage bone pain.
2. A patient with breast cancer and bone metastases undergoes Strontium sr-89 chloride treatment to alleviate pain and improve quality of life.
3. A patient with lung cancer and bone metastases receives Strontium sr-89 chloride therapy as part of their palliative care plan.
4. A patient with multiple myeloma undergoes Strontium sr-89 chloride treatment to target bone lesions and reduce pain.
5. A patient with metastatic melanoma and bone involvement receives Strontium sr-89 chloride therapy to alleviate symptoms and improve comfort.